Shots:
- Hologic acquired Somatex Medical Technologies for ~$64M. The acquisition of Somatex’s differentiated products will enable Hologic to strengthen & expand its breast marker portfolio
- The acquisition allows the company to expand its biopsy portfolio with the improvement in the biopsy experience for their patients. The acquisition provides Hologic additional expertise and capabilities to continue to grow its breast health portfolio
- Somatex specializes in the development & manufacturing of minimally invasive devices in the areas of tumor diagnostics, biopsy and interventional specialties and includes the Tumark family of tissue markers, which were distributed by Hologic in the US prior to the acquisition
Click here to read full press release/ article | Ref: Hologic | Image: Mass Device
The post Hologic to Acquire Somatex for ~$64 M first appeared on PharmaShots.
